Private Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Sell
81,843
-294
-0.4% -$7.69K 0.05% 190
2026
Q1
$2.31M Buy
82,137
+1,038
+1% +$27.6K 0.07% 174
2025
Q4
$2.02M Sell
81,099
-474
-0.6% -$12K 0.06% 175
2025
Q3
$2.08M Sell
81,573
-200
-0.2% -$4.94K 0.06% 168
2025
Q2
$1.98M Buy
81,773
+5,363
+7% +$125K 0.06% 162
2025
Q1
$1.94M Sell
76,410
-58
-0.1% -$1.52K 0.07% 131
2024
Q4
$2.03M Sell
76,468
-438
-0.6% -$11.9K 0.07% 130
2024
Q3
$2.23M Sell
76,906
-401
-0.5% -$11.7K 0.08% 127
2024
Q2
$2.16M Buy
77,307
+50,728
+191% +$1.4M 0.08% 128
2024
Q1
$738K Buy
26,579
+19,409
+271% +$539K 0.03% 150
2023
Q4
$206K Buy
7,170
+399
+6% +$12.1K 0.01% 196
2023
Q3
$225K Sell
6,771
-60
-0.9% -$2.12K 0.01% 177
2023
Q2
$251K Buy
6,831
+616
+10% +$24K 0.01% 172
2023
Q1
$254K Buy
6,215
+1,767
+40% +$76.3K 0.01% 166
2022
Q4
$228K Buy
+4,448
New +$213K 0.01% 171

Other funds holding PFE

Private Management Group's PFE Position: Q2 2026 in Review

Private Management Group reduced its Pfizer (PFE) stake by 0.36% in Q2 2026, selling an estimated $7.69K and leaving 81,843 shares worth $1.97M. The position accounts for 0.05% of the portfolio, ranked #190.

Private Management Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.31M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Private Management Group held 81,843 shares of Pfizer worth $1.97M as of Q2 2026.
  • Private Management Group sold 294 Pfizer shares in Q2 2026, an estimated $7.69K.
  • Pfizer made up 0.05% of Private Management Group's portfolio in Q2 2026, its #190 holding.
  • Private Management Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Private Management Group's Pfizer position peaked at $2.31M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.